Hedera Dx
ID: 16282910Hedera Dx is a blood-based cancer testing solutions provider founded in 2021 by Tommi Lehtonen, Damien Lapray and Christian Meisel.
1
Funding Rounds
$17.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| To*** Le****** |
|
- | |
| Da**** La**** |
|
- | |
| Ch******* Me**** |
|
- |
Funding series
Funding Series Analysis
The company Hedera Dx has raised a total of $17m in funding over 1 rounds.
Key Insights:
- Hedera Dx Series A Round, May 2025: $17m
Industries
Hedera Dx is active in the following industries: